The Food and Drug Administration (FDA) on Thursday said Covid-19 vaccines could be approved for full authorization by next year.

“My prediction, siguro early next year, by the first quarter—not only Pfizer—maybe several of the existing vaccines will get full approval for marketing authorization,” FDA chief Eric Domingo said in an interview over ANC.

Vaccines being deployed nationwide are under emergency use licenses.

This means the government has to be involved in vaccine procurement because the shots have yet to earn commercial use licenses.

Domingo said the FDA was “eagerly waiting” for vaccine manufacturers to apply for full authorization.

He added that vaccine clinical trials were likely to be completed by yearend.

“Once they consolidate all of that data, most of these vaccines will probably start applying, not just in Philippine FDA but all FDAs all over the world,” he said.

The Pfizer-BioNTech vaccine was granted full approval by the US FDA in August 2021.

Domingo said the manufacturers of the Pfizer vaccine were still in the process of completing their documents and requirements for local approval. John Ezekiel J. Hirro